# Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study

> **NCT03120533** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 18 (actual)

## Conditions studied

- Scleroderma, Systemic

## Interventions

- **DRUG:** Iontophoresis of treprostinil
- **DRUG:** Iontophoresis of placebo

## Key facts

- **NCT ID:** NCT03120533
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-20
- **Primary completion:** 2019-06-03
- **Final completion:** 2019-06-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-04-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03120533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03120533, "Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03120533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*